Harbin Gloria Pharmaceuticals Co Ltd (002437)-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Harbin Gloria Pharmaceuticals Co Ltd (002437) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013450
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月28日
◆ページ数:20
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:中国
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Harbin Gloria Pharmaceuticals Co Ltd (Harbin Gloria) is a pharmaceutical company that produces and markets nutritional drugs. The company’s products comprise pharmaceutical drugs for treating nutrition disorders, cardiovascular diseases, cancer and musculoskeletal disorders. Its pipeline products include lubiprostone, developed for chronic idiopathic constipation, opioid-induced constipation, irritable bowel syndrome with constipation in women. Harbin Gloria also offers SX-004 for the treatment of acute leukemias and solid tumors. The company collaborates with hospitals and institutions to carry out its research activities. Harbin Gloria is headquartered in Beijing, China.

Harbin Gloria Pharmaceuticals Co Ltd (002437) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Harbin Gloria Pharmaceuticals Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Harbin Gloria Pharmaceuticals Co Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Harbin Gloria Pharmaceuticals Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Harbin Gloria Pharmaceuticals Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Harbin Gloria Pharmaceuticals Co Ltd, Medical Devices Deals, 2011 to YTD 2017 9
Harbin Gloria Pharmaceuticals Co Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Harbin Gloria Pharmaceuticals Co Ltd, Pharmaceuticals & Healthcare, Deal Details 11
Licensing Agreements 11
Arcus Biosciences Enters into Licensing Agreement with Wuxi Biologics and Harbin Gloria Pharma for GLS-010 11
Equity Offering 12
Harbin Gloria Pharma Raises USD3.7 Million in Private Placement of Shares 12
Harbin Gloria Pharma Completes Spin-Off of Two Subsidiaries 13
Harbin Gloria Pharma to Raise USD628.7 Million in Private Placement of Shares 14
Debt Offering 15
Harbin Gloria Pharma to Raise USD243 Million in Public Offering of Notes Due 2019 15
Harbin Gloria Pharma Raises USD72.8 Million in Public Offering of 5.1% Notes Due 2020 16
Harbin Gloria Pharmaceuticals Co Ltd – Key Competitors 17
Harbin Gloria Pharmaceuticals Co Ltd – Key Employees 18
Harbin Gloria Pharmaceuticals Co Ltd – Locations And Subsidiaries 19
Head Office 19
Other Locations & Subsidiaries 19
Appendix 20
Methodology 20
About GlobalData 20
Contact Us 20
Disclaimer 20

List of Tables
Harbin Gloria Pharmaceuticals Co Ltd, Pharmaceuticals & Healthcare, Key Facts, 2016 2
Harbin Gloria Pharmaceuticals Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Harbin Gloria Pharmaceuticals Co Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Harbin Gloria Pharmaceuticals Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Harbin Gloria Pharmaceuticals Co Ltd, Deals By Therapy Area, 2011 to YTD 2017 8
Harbin Gloria Pharmaceuticals Co Ltd, Medical Devices Deals, 2011 to YTD 2017 9
Harbin Gloria Pharmaceuticals Co Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Arcus Biosciences Enters into Licensing Agreement with Wuxi Biologics and Harbin Gloria Pharma for GLS-010 11
Harbin Gloria Pharma Raises USD3.7 Million in Private Placement of Shares 12
Harbin Gloria Pharma Completes Spin-Off of Two Subsidiaries 13
Harbin Gloria Pharma to Raise USD628.7 Million in Private Placement of Shares 14
Harbin Gloria Pharma to Raise USD243 Million in Public Offering of Notes Due 2019 15
Harbin Gloria Pharma Raises USD72.8 Million in Public Offering of 5.1% Notes Due 2020 16
Harbin Gloria Pharmaceuticals Co Ltd, Key Competitors 17
Harbin Gloria Pharmaceuticals Co Ltd, Key Employees 18
Harbin Gloria Pharmaceuticals Co Ltd, Other Locations 19

★海外企業調査レポート[Harbin Gloria Pharmaceuticals Co Ltd (002437)-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Sekisui House Ltd (1928):企業の財務・戦略的SWOT分析
    Sekisui House Ltd (1928) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Sisaf Ltd-医療機器分野:企業M&A・提携分析
    Summary Sisaf Ltd (Sisaf) is a drug delivery company which designs and develops topical delivery systems for cosmetic, medical, and skin care applications. The company manufactures and markets products and drug delivery solutions using ProSilic, a nano-silicon technology platform. It offers ProSilli …
  • Par Pacific Holdings Inc (PARR):企業の財務・戦略的SWOT分析
    Par Pacific Holdings Inc (PARR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • TiVo Corp.:企業の戦略・SWOT・財務情報
    TiVo Corp. - Strategy, SWOT and Corporate Finance Report Summary TiVo Corp. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • MicroPort Scientific Corp (853):医療機器:M&Aディール及び事業提携情報
    Summary MicroPort Scientific Corp (MicroPort) a subsidiary of Otsuka Medical Devices Co Ltd is a medical device company which develops, manufactures and markets cardiovascular treatment devices. The company provides products such as cardiovascular devices, orthopedic devices, endovascular devices, e …
  • Imperial College London-製薬・医療分野:企業M&A・提携分析
    Summary Imperial College London (Imperial) is a research university that offers educational services. The university provides undergraduate and postgraduate courses. It offers courses in the field of science and technology, agriculture, business, the humanities, and medicine. It conducts clinical tr …
  • DURECT Corp (DRRX):企業の財務・戦略的SWOT分析
    DURECT Corp (DRRX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Zeta Petroleum Plc (ZTA):石油・ガス:M&Aディール及び事業提携情報
    Summary Zeta Petroleum Plc (Zeta) is an oil and gas exploration and production company. The company explores, develops and produces natural gas and crude oil. It owns and operates oil and gas assets such as Bobocu Gas Field, Suceava Concession, Jimbolia Oil Field, and Grivita Nord Oil Field. Zeta’s …
  • TH Heavy Engineering Bhd (THHEAVY):石油・ガス:M&Aディール及び事業提携情報
    Summary TH Heavy Engineering Bhd (TH Heavy), formerly Ramunia Holding Bhd, is a provider of heavy engineering services. It offers offshore steel structures fabrication and other related offshore and onshore oil and gas engineering services. The company specializes in fabrication, construction and ma …
  • American Greetings Corporation:企業の戦略・SWOT・財務情報
    American Greetings Corporation - Strategy, SWOT and Corporate Finance Report Summary American Greetings Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Petroleos Mexicanos-エネルギー分野:企業M&A・提携分析
    Summary Petroleos Mexicanos (PEMEX) is a state owned vertically integrated oil and gas company. The company explores for, develops and produces crude oil and natural gas. It also refines and markets petroleum products. PEMEX gathers and processes natural gas products. It manufactures and markets a w …
  • Hays plc (HAS):企業の財務・戦略的SWOT分析
    Hays plc (HAS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the po …
  • Andrew Peller Limited:企業の戦略・SWOT・財務分析
    Andrew Peller Limited - Strategy, SWOT and Corporate Finance Report Summary Andrew Peller Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Scripps Networks Interactive, Inc.:企業のM&A・事業提携・投資動向
    Scripps Networks Interactive, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Scripps Networks Interactive, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on m …
  • Oneida Ltd.:企業の戦略的SWOT分析
    Oneida Ltd. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Lexicon Pharmaceuticals Inc (LXRX):企業の財務・戦略的SWOT分析
    Lexicon Pharmaceuticals Inc (LXRX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • United States Lime & Minerals Inc:企業の戦略・SWOT・財務分析
    United States Lime & Minerals Inc - Strategy, SWOT and Corporate Finance Report Summary United States Lime & Minerals Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Meijer Inc:企業の戦略・SWOT・財務情報
    Meijer Inc - Strategy, SWOT and Corporate Finance Report Summary Meijer Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Hollysys Automation Technologies Ltd:企業の戦略・SWOT・財務分析
    Hollysys Automation Technologies Ltd - Strategy, SWOT and Corporate Finance Report Summary Hollysys Automation Technologies Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysi …
  • Black Hills Corporation:発電所・企業SWOT分析
    Black Hills Corporation - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key emplo …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆